Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens0On 2018-05-282018-05-28By Bioinformatics Solutions IncIn User PublicationsTernette, N., et al. Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens. Proteomics. e1700465. 28/5/2018.